Form D · Pharmaceuticals
AERIE PHARMACEUTICALS INC
Bedminster, NJ · CIK 0001337553
Offering snapshot reported Sep 23, 2014 · SEC filing
- Reported sold
- $125M Offering amount: $125M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 8, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 23, 2014 | Initial | $125,000,000 | No comparison | 5 | SEC filing |
| Aug 29, 2013 | Amendment | $15,000,000 | $12,000,000vs Dec 19, 2012 | 5 | SEC filing |
| Dec 19, 2012 | Initial | $3,000,000 | No comparison | 5 | SEC filing |
| Mar 1, 2011 | Initial | $41,364,965 | No comparison | 8 | SEC filing |
| Sep 1, 2010 | Initial | $5,250,000 | No comparison | 3 | SEC filing |
| Mar 2, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Oct 11, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 26, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-225197
Source: Form D, filed Sep 23, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Vicente Anido | Director, Executive |
| Gerald Cagle | Director |
| Janet Conway | Director |
| Mitchell De Long | Executive |
| Geoffrey Duyk | Director |
| David Epstein | Director |
| Murray Goldberg | Director |
| David Gryska | Director |
| Dennis Henner | Director |
| Casey Kopczynski | Executive |
| Brian Levy | Executive |
| David Mack | Director |
| James Mazzo | Director |
| Anand Mehra | Director |
| Thomas Mitro | Executive |
| Richard Rubino | Executive |
| Thomas J Van Haarlem | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
135 Us Highway 206 Suite 15
Bedminster, NJ, 07921
Bedminster, NJ, 07921